NCT05772520: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis |
|
|
| Recruiting | 2 | 120 | US | TLL018 tablets, TLL018 Placeboes | Hangzhou Highlightll Pharmaceutical Co., Ltd | Plaque Psoriasis | 04/24 | 05/24 | | |
| Recruiting | 3 | 330 | US | Candin, Intradermal Solution, Placebo | Nielsen BioSciences, Inc. | Common Warts (Verruca Vulgaris) | 06/25 | 06/25 | | |
NCT05772520: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis |
|
|
| Recruiting | 2 | 120 | US | TLL018 tablets, TLL018 Placeboes | Hangzhou Highlightll Pharmaceutical Co., Ltd | Plaque Psoriasis | 04/24 | 05/24 | | |